— Know what they know.
Not Investment Advice

CBDG OTC

THC Farmaceuticals, Inc.
1W: +0.0% 1M: -14.0% 3M: +118.2% YTD: -36.8% 1Y: +83.2% 3Y: -86.7% 5Y: -93.3%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $435158 mcap · 18M float · 0.0034% daily turnover · Short 80% of daily vol

Balance Sheet Trends

Total Assets
$3M -1.1% ▼
5Y CAGR: -0.1%
Total Liabilities
$142K +0.0% ▲
5Y CAGR: -31.7%
Shareholders Equity
$3M -0.5% ▼
5Y CAGR: +12.1%
Cash & Investments
$2K +0.0% ▲
5Y CAGR: -44.2%
Total Debt
$142K +0.0% ▲
5Y CAGR: -31.2%
Net Debt
$140K +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$3K$3K$19K$2K$2K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3K$3K$19K$2K$2K
Net Receivables$623K$631K$635K$636K$15K
Inventory$0$0$0$0$0
Other Current Assets$25K$25K$25K$25K$0
Total Current Assets$651K$658K$679K$663K$16K
Property, Plant & Equip.$8K$7K$6K$23K$18K
Goodwill & Intangibles$2M$2M$1M$2M$2M
Long-Term Investments$645K$645K$1M$450K$1M
Other Non-Current Assets-$1M-$1M$0$0$0
Total Non-Current Assets$2M$2M$2M$2M$3M
Total Assets$3M$2M$3M$3M$3M
— Liabilities —
Accounts Payable$11K$30K$30K$0$0
Short-Term Debt$917K$343K$373K$142K$142K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$159K$179K$185K$577$577
Total Current Liabilities$1M$551K$588K$142K$142K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$1M$551K$588K$142K$142K
— Equity —
Common Stock$17K$17K$18K$18K$18K
Retained Earnings-$2M-$2M-$2M-$1M-$1M
Accumulated OCI$645K$645K$645K$645K$645K
Total Stockholders Equity$2M$2M$3M$3M$3M
Total Liabilities & Equity$3M$2M$3M$3M$3M
— Key Metrics —
Total Debt$917K$343K$373K$142K$142K
Net Debt$914K$340K$354K$140K$140K
Total Investments$645K$645K$1M$450K$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms